Form4insider filings, from the source

Insider holders · CIK 0000744218

Celldex Therapeutics, Inc. · CLDX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Richard van den BroekDirector233,500—233,500Jun 9, 2016 · 4:29 pm EDTForm 4
Gerald McMahon Ph.D.Director180,697—180,697Dec 4, 2018 · 7:35 am ESTForm 4
Avery W CatlinSr. VP & CFO83,586—83,586Sep 7, 2016 · 12:59 pm EDTForm 4
Larry EllbergerDirector73,500—73,500Jun 16, 2017 · 9:29 am EDTForm 4
James J MarinoDirector65,997—65,997Aug 28, 2018 · 7:34 am EDTForm 4
Anthony S MarucciPresident and CEO50,028—50,028Aug 14, 2015 · 8:01 am EDTForm 4
Harry Penner Jr.Director41,916—41,916Jun 16, 2017 · 9:29 am EDTForm 4
Karen Shoos LiptonDirector41,833—41,833Jun 16, 2017 · 9:29 am EDTForm 4
Herbert J ConradDirector38,500—38,500Jun 16, 2017 · 9:29 am EDTForm 4
Tibor KelerExecutive VP & CSO35,368—35,368Jun 18, 2018 · 8:15 am EDTForm 4
George ElstonDirector28,500—28,500Jun 9, 2016 · 4:28 pm EDTForm 4
Keith L BrownlieDirector10,000—10,000Jun 16, 2017 · 9:32 am EDTForm 4
Elizabeth CrowleySVP, Chief Product Dev Officer7,322—7,322Aug 12, 2016 · 7:58 am EDTForm 3
Sarah CavanaughSVP of Corp. Affairs & Admin.4,760—4,760Jun 16, 2017 · 9:05 am EDTForm 3
Richard M. WrightSr. VP & CCO3,125—3,125Jul 1, 2015 · 9:10 am EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.